218 related articles for article (PubMed ID: 37794170)
1. Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?
Lam WKJ; Chan ATC
Nat Rev Clin Oncol; 2024 Jan; 21(1):6-7. PubMed ID: 37794170
[No Abstract] [Full Text] [Related]
2. Anti-BNLF2b Screening for Nasopharyngeal Cancer.
Ren T
N Engl J Med; 2023 Nov; 389(19):1824-1825. PubMed ID: 37937787
[No Abstract] [Full Text] [Related]
3. Anti-BNLF2b Screening for Nasopharyngeal Cancer.
Yan K
N Engl J Med; 2023 Nov; 389(19):1824. PubMed ID: 37937786
[No Abstract] [Full Text] [Related]
4. Anti-BNLF2b Screening for Nasopharyngeal Cancer. Reply.
Li T; Ji M; Xia N
N Engl J Med; 2023 Nov; 389(19):1825. PubMed ID: 37937788
[No Abstract] [Full Text] [Related]
5. Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies.
Tang IYK; Li TWL; Luk LTH; Ho B; Ho R; Lai BTL; Lee PML; So H
Int J Rheum Dis; 2024 Jun; 27(6):e15215. PubMed ID: 38873854
[No Abstract] [Full Text] [Related]
6. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.
Lam WKJ; King AD; Miller JA; Liu Z; Yu KJ; Chua MLK; Ma BBY; Chen MY; Pinsky BA; Lou PJ; Woo JKS; Hsu WL; Simon J; Doolan DL; Waterboer T; Hui EP; Li H; Tsang RK; Wong KCW; Goh JP; Vlantis AC; Ai QY; Wong LM; Abdullah V; Lin JC; Chen CJ; Pfeiffer RM; Le QT; Lee AWM; Ji M; Cao S; Ma J; Chan ATC; Chan KCA; Hildesheim A
J Natl Cancer Inst; 2023 Apr; 115(4):355-364. PubMed ID: 36723440
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Diagnosing a Submucosal Nasopharyngeal Carcinoma by Endonasopharyngeal Ultrasound-Guided Transnasopharyngeal Needle Aspiration.
Zhang ZM; Bao Y; Zhou LX; Zhao R; Huang J; Liu WS
Chin Med J (Engl); 2018 Jun; 131(12):1506-1508. PubMed ID: 29893374
[No Abstract] [Full Text] [Related]
10. Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".
Liu Z; Ye W; Zeng YX; Cao SM
Am J Epidemiol; 2013 Feb; 177(3):254-5. PubMed ID: 23255782
[No Abstract] [Full Text] [Related]
11. Advances of biomarkers in nasopharyngeal carcinoma's early detection.
Zheng XH; Hildesheim A; Jia WH
Sci Bull (Beijing); 2024 Jan; 69(2):141-145. PubMed ID: 38087738
[No Abstract] [Full Text] [Related]
12. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
13. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
[TBL] [Abstract][Full Text] [Related]
14.
Lyu JY; Chen JY; Zhang XJ; Zhang MW; Yu GS; Zhang L; Wen Z
Dis Markers; 2020; 2020():7253531. PubMed ID: 32454907
[TBL] [Abstract][Full Text] [Related]
15. Ambient Temperature and Screening for Nasopharyngeal Cancer.
Chan KCA; Chu SWI; Lo YMD
N Engl J Med; 2018 Mar; 378(10):962-963. PubMed ID: 29514031
[No Abstract] [Full Text] [Related]
16. Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
Nierengarten MB
Cancer; 2024 Jan; 130(2):172. PubMed ID: 38251417
[No Abstract] [Full Text] [Related]
17. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
18. Screening for Nasopharyngeal Cancer in High-Risk Populations: A Small Price to Pay for Early Disease Identification?
de Almeida JR; Bratman SV; Hansen AR
J Natl Cancer Inst; 2021 Jul; 113(7):803-804. PubMed ID: 33351096
[No Abstract] [Full Text] [Related]
19. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
[TBL] [Abstract][Full Text] [Related]
20. [Rare Differential Diagnosis of a Nasopharyngeal Mass].
Heidary M; Schultz J; Dominas N
Laryngorhinootologie; 2022 Apr; 101(4):331-332. PubMed ID: 34348407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
